| Home : Diadem Presents New Data at AAIC® Symposium Showing Its Blood-Based Biomarker Test Accurately Predicts Progression to Alzheimer's Disease 7 Years Before Symptoms Occur |
|
May 13
2021 |
Diadem Presents New Data at AAIC® Symposium Showing Its Blood-Based Biomarker Test Accurately Predicts Progression to Alzheimer's Disease 7 Years Before Symptoms Occur |
|
MILAN, Italy, May 13, 2021 /PRNewswire/ -- Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced new data showing that its AlzoSure® prognostic biomarker test can accurately predict progression to Alzheimer's... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/diadem-presents-new-data-at-aaic-symposium-showing-its-blood-based-biomarker-test-accurately-predicts-progression-to-alzheimers-disease-7-years-before-symptoms-occur-301290455.html |
| |
|
Related News
|
» New Tezepelumab Data Continue To Strengthen Profile For A Broad Population Of Severe Asthma Patients
» Times Square shooting suspect arrested by US Marshals in Florida
|
